Ola Ahmed

Nephrology Trainee

[Ola Ahmed @NephFanatic]

@GlassockJ @NephRodby What’s your take Dr Glassock on the type of creatine supplement? It would be good to know if there’s a difference to look out for

[Aravind Palraj @Rheumat_Aravind]

🧵 Thread: Rheumatoid Factor (RF)

Tweet 1 (Intro):
🤔 What exactly is Rheumatoid Factor (RF)?
One of the oldest autoantibodies in medicine, it’s famous for its role in Rheumatoid Arthritis but has many more stories to tell.

🧵 A complete breakdown 👇
@IhabFathiSulima @DrAkhilX @CelestinoGutirr #MedTwitter #RheumTwitter

[Naoka Murakami @nymurakami]

💡New resources- Management recommendations for kidney transplantation in patients with plasma cell dyscrasia. Useful info on pre-tx eval, post-tx monitoring of recurrence, immunosuppression mgmt. @Kidney_Int
@AST_KPCOP w IKMG. More info 👇. https://t.co/9eWhU7EcR9

[Aravind Palraj @Rheumat_Aravind]

1️⃣ What do C3 and C4 measure?
✅ C3 and C4 are proteins in the classical and alternative complement pathways.
📌 Decreased levels = consumption (immune complexes) or decreased synthesis.

[Ola Ahmed @NephFanatic]

What a fantastic experience! I'm so grateful for the opportunity to have been part of the GlomCon Fellowship 2025🤩

Now all geared up and ready to dive deeper into the fascinating world of glomerular diseases! 🏊‍♀️

Thank you to the incredible faculty, thank you @GlomCon

[ISN Education @ISNeducation]

21/n #ECNeph @myadla @ISNkidneycare @Dilushiwijay @krithicism
Paraneoplastic glomerular diseases
Great VA by @nephromythri
https://t.co/VaN8WjDi7H

[Int Society of Nephrology @ISNkidneycare]

🚨 Cardiorenal Syndrome (CRS): A Deadly Duo 🚨
Did you know the heart & kidneys are so intertwined that dysfunction in one can wreak havoc on the other?
Let's dive into CRS today.
A lucid read for every nephrology & cardiology fellow 🫀🩺
#MedTwitter
#ISNTweetorial

[Arunkumar @Arunkr_Dr]

ANCA vasculitis & plasma exchange—still a gray zone?

🧪 PEXIVAS said no routine role, but real-world practice often begs nuance.

Did PEXIVAS really settle the debate?

Let’s debate at #ERA25 #NephTwitter #RheumTwitter #MedTwitter #Vasculitis

Methods of antibody removal 👇👇👇

[Hans-Joachim Anders @hjanders_hans]

Now open access in @NDTsocial

Antibody-mediated Rejection - Treatment Standard

🧐Ongoing phase 2 trials offer hope for effective, therapies targeting different aspects of AMR.

▶️https://t.co/1UNJNYYIK7

[Jasmine Sethi @JasmineNephro]

🫘🎯Kidney involvement in Monoclonal gammopathy of renal significance

@KIReports

https://t.co/435EFpyLki

[Amy Yau @amyaimei]

Patients with Hz-vasculitis had a
💊mean daily dose of 142 mg
📆mean exposure time of 4.7 years.

The higher the dose, the higher the incidence.

https://t.co/WLGbYJSiE1

[Jasmine Sethi @JasmineNephro]

🦋Lupus nephritis-Nice infographic

@KidneyKolumns

[Jasmine Sethi @JasmineNephro]

🎯🫘ANCA Vasculitis -One infographic summary of KDIGO guidelines

@KidneyKolumns @goKDIGO

[AJKD @AJKDonline]

NEW Commentary by @yari_nephro and @shanebobart #AJKDBlog:

The future of #IgAN treatment is multi-targeted and personalized. Is the future now?
https://t.co/DiYplo7g1Z

Review by @dawn_caster and @kidneybiz: https://t.co/DiYplo7g1Z

[Nature Reviews Nephrology @NatRevNeph]

Pathophysiology of immune checkpoint inhibitor-associated acute kidney injury.

https://t.co/gjcRO8MoCo

[Jasmine Sethi @JasmineNephro]

🙇‍♀️C3G and Ig MPGN-How do u treat

First rule out

✅Autoimmune Ds-Sjögren/SLE/Cryo

✅Infection-HBV/HCV/IE

✅Monoclonal gammopathy

➡️Screen complement abnormalities

💊Treatment -Renoprotection for all👇

👍IST-Rapid gfr decline-MMF/steroids trial

💉Complement inhibitors

@NDTsocial

https://t.co/8oJGTFDjqH

[Jithu Kurian🇮🇳 @Jithukurian6]

🔥 Let’s discuss about Chronic Kidney Disease - Mineral Bone disease (CKD- MBD)

🔥 This is what I thought it was as a student… I was wrong ❌

🔥Did you also think so ? #NephTwitter #MedTwitter #Medpearls

[Sanjiv J. Shah, MD @HFpEF]

1/ #HFpEF treatment algorithm #tweetorial. This is the algorithm I currently use to treat HFpEF based on evidence we have thus far and my anecdotal experience treating patients over the past 16 years in the @NMCardioVasc HFpEF Clinic.

[KIReports @KIReports]

2/The correct answer is Steroids. Avacopan is a new treatment agent in ANCA associated vasculitis (AAV) that can potentially reduce the use of steroids.

[AJKD @AJKDonline]

Renal Thrombotic Microangiopathy: A Review

https://t.co/YabUm18t4q (FREE)

@CPQMD @ReichHeather @UofTNephrology